UnknownPHASE2, PHASE3NCT00391144
Avastin for CNV Secondary to Pattern Dystrophy
Studying Pattern dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Trieste
- Principal Investigator
- Maurizio B Parodi, MDClinica Oculistica, Azienda Ospedaliero-Universitaria di Trieste
- Intervention
- intravitreal triamcinolone injection of avastin (1.25 mg)(procedure)
- Enrollment
- 5 enrolled
- Eligibility
- 20-80 years · All sexes
- Timeline
- 2006 – 2006
Study locations (1)
- Clinica Oculistica, Azienda Ospedaliero-Universitaria di Trieste, Trieste, TS, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00391144 on ClinicalTrials.gov